NCT02377258View on ClinicalTrials.gov

IBD Cancer and Serious Infection in Europe

CompletedOBSERVATIONAL
Enrollment

13,262

Participants

Timeline

Start Date

March 4, 2016

Primary Completion Date

May 16, 2022

Study Completion Date

May 16, 2022

Conditions
IBD
Interventions
OTHER

Non Interventional

Trial Locations (1)

54500

Chu Nancy, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

OTHER

NCT02377258 - IBD Cancer and Serious Infection in Europe | Biotech Hunter | Biotech Hunter